Mo Chen
Taithera, Inc.
Technologies
Therapeutic
Indication
Musculoskeletal Disorders
Oncology
Orphan Diseases
Executive Summary
View/DownloadWebsite
www.taithera.comTaithera is a revolutionary nanomedicine bone-targeted drug delivery and controlled release platform technology for the treatment of musculoskeletal conditions focused initially on fracture healing & bone cancer (osteosarcoma is our first oncology target).
